Moreover, downregulation of ZFP36 led to aberrant high expression of BARX1, followed by activation of downstream master oncogenes CDC20, CDC45, TRIM37 and MMP-9, thereby promoting in vitro proliferation, migration, invasion and in vivo tumorigenicity of NSCLC cells. The gene discussed is BARX1; the disease is non-small cell lung carcinoma.